The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cytokine and Cytokine Receptor Pleiotropy and Redundancy
Open accessAbstract
interleukin granulocyte-macrophage colony-stimulating factor leukemia inhibitory factor oncostatin M ciliary neurotrophic factor novel neurotrophin-1/B cell-stimulating factor-3/cardiotrophin-like cytokine cardiotrophin-1 LIF receptor thymic stromal lymphopoietin X-linked severe combined immunodeficiency natural killer TSLP receptor interferon Cytokines represent a diverse group of molecules that collectively exert a wide range of actions (1Leonard W.J. Paul W.E. Fundamental Immunology. 4th Ed. Lippincott-Raven Publishers, Philadelphia1999: 741-774Google Scholar). The term cytokine is rather general, technically referring to a molecule made by one cell that acts on another, but cytokines are primarily growth factors and hormones of the immune and hematopoietic systems. The term broadly encompasses many of the interleukins and colony-stimulating factors (which are also referred to as type I cytokines) and interferons (which sometimes are referred to as type II cytokines) (1Leonard W.J. Paul W.E. Fundamental Immunology. 4th Ed. Lippincott-Raven Publishers, Philadelphia1999: 741-774Google Scholar). Certain molecules, such as erythropoietin, thrombopoietin, growth hormone, and prolactin, although not classically thought of as typical cytokines, have similar structures and signaling mechanisms to type I cytokines (1Leonard W.J. Paul W.E. Fundamental Immunology. 4th Ed. Lippincott-Raven Publishers, Philadelphia1999: 741-774Google Scholar). Many individual cytokines are themselves pleiotropic, exerting multiple actions, and particularly in vitro, many cytokines have overlapping actions (2Paul W.E. Cell. 1989; 57: 521-524Abstract Full Text PDF PubMed Scopus (200) Google Scholar, 3Leonard W.J. Curr Opin. Immunol. 1994; 6: 631-635Crossref PubMed Scopus (53) Google Scholar). There are multiple different possible mechanisms that can explain pleiotropic and overlapping actions for different cytokines. Pleiotropic actions can be explained by the presence of receptors for a cytokine on multiple lineages or by a cytokine having the ability to activate multiple signaling pathways wherein different signaling pathways differentially contribute to different functions. Overlapping actions by different cytokines can be explained by similar cellular distributions of specific receptors for different cytokines as well as by the sharing of signaling pathways, which particularly occurs when different receptors share similar motifs that mediate the coupling to the same pathways. In addition, however, cytokine pleiotropy and redundancy can be at least partially explained, respectively, by the ability of certain cytokines to signal via more than one type of receptor complex and by the sharing of an individual receptor component by more than one cytokine. We will herein summarize a range of different systems wherein cytokine receptor components are shared, discussing the implications thereof. For type I cytokines, these include the sharing of the common β chain, βc, by interleukin-3 (IL-3),1 IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF); the sharing of gp130 by IL-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), novel neurotrophin-1/B cell-stimulating factor-3/cardiotrophin-like cytokine (NNT-1/BSF-3/CLC), and cardiotrophin-1 (CT-1); the sharing of LIFRβ by LIF, OSM, CNTF, NNT-1/BSF-3/CLC, and CT-1; the sharing of CNTFRα by CNTF and NNT-1/BSF-3/CLC; the sharing of IL-12Rβ1 by IL-12 and IL-23; the sharing of γc by IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21; the sharing of IL-2Rβ by IL-2 and IL-15; the sharing of IL-4Rα and IL-13Rα1 by IL-4 and IL-13; and the sharing of IL-7Rα by IL-7 and thymic stromal lymphopoietin (TSLP) (Table I). The cytokines that can signal via more than one complex include IL-2, IL-4, human OSM, and murine IL-3. For type II cytokines, we discuss the sharing of IL-10Rβ by IL-10 and IL-22, the sharing of IL20Rα and IL-20Rβ by IL-19, IL-20, and IL-24, and the sharing of IL-22Rα by IL-20, IL-22, and IL-24.Table ISharing of receptor subunits by multiple type I cytokinesShared subunitOther componentsLigandIL-3RαβcHuman or murine IL-3βIL-3Murine IL-3βcIL-3RαIL-3GM-CSFRαGM-CSFIL-5RαIL-5gp130IL-6RαIL-6IL-11RαIL-11CNTFRα and LIFRβCTNFLIFRβLIFLIFRβOSM (human)OSMRβOSM (human or murine)LIFRβ and CNTFRαNNT-1/BSF-3/CLCLIFRβ and ?CT-1LIFRβgp130LIFgp130OSM (human)CNTFRα, gp130CNTFgp130 and CNTFRαNNT-1/BSF-3/CLCgp130 and ?CT-1CNTFRαgp130 and LIFRβCNTFgp130 and LIFRβNNT-1/BSF-3/ CLC plus CLF1IL-12Rβ1IL-12Rβ2IL-12IL-23RIL-23γcIL-2Rα, IL-2RβIL-2 (high affinity receptor)IL-2RβIL-2 (intermediate affinity receptor)IL-4RαIL-4IL-7RαIL-7IL-9RαIL-9IL-15Rα, IL-2RβIL-15IL-21RαIL-21IL-2RβγcIL-2 (high affinity receptor)IL-2Rα, γcIL-2 (intermediate affinity receptor)IL-15Rα, γcIL-15IL-4RαγcIL-4 (type I receptor)IL-13Rα1IL-4 (type II receptor)IL-13Rα1IL-4RαIL-4 (type II receptor)IL-4RαIL-13IL-7RαγcIL-7TSLPRTSLP Open table in a new tab The basic understanding of type I cytokine-r
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1955 · Cited by 1,555
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E., & Murray, R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1519 · Cited by 1,428
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
IL-15 Receptor Maintains Lymphoid Homeostasis by Supporting Lymphocyte Homing and Proliferation
Lodolce, J. P., Boone, D. L., Chai, S., Swain, R. E., Dassopoulos, T., Trettin, S., & Ma, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80664-0 · Cited by 1,299
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Potent and Selective Stimulation of Memory-Phenotype CD8+ T Cells In Vivo by IL-15
Zhang, X., Sun, S., Hwang, I., Tough, D. F., & Sprent, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80564-6 · Cited by 1,245
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J., Madden, K., Xu, W., West, J., et al. (2000) · Nature · doi:10.1038/35040504 · Cited by 1,224
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203
Anderson, P. C. (1999) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.281.24.2351 · Cited by 1,006
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
Schorle, H., Holtschke, T., Hünig, T., Schimpl, A., & Horak, I. (1991) · Nature · doi:10.1038/352621a0 · Cited by 879
Cloning of the γ Chain of the Human IL-2 Receptor
Takeshita, T., Asao, H., Ohtani, K., Ishii, N., Kumaki, S., Tanaka, N., Munakata, H., Nakamura, M., & Sugamura, K. (1992) · Science · doi:10.1126/science.1631559 · Cited by 840
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
Self-citationInterleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Lin, J.-X., Migone, T.-S., Tseng, M., Friedmann, M., Weatherbee, J. A., Zhou, L., Yamauchi, A., Bloom, E. T., Mietz, J., John, S., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90141-8 · Cited by 752
Self-citationYoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 635
Mosley, B., Beckmann, M. P., March, C. J., Idzerda, R. L., Gimpel, S. D., VandenBos, T., Friend, D., Alpert, A., Anderson, D., Jackson, J., et al. (1989) · Cell · doi:10.1016/0092-8674(89)90295-x · Cited by 624
Hayashida, K., Kitamura, T., Gorman, D. M., Arai, K., Yokota, T., & Miyajima, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9655 · Cited by 609
Kitamura, T., Sato, N., Arai, K.-I., & Miyajima, A. (1991) · Cell · doi:10.1016/0092-8674(91)90039-2 · Cited by 595
Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S., Liggitt, D., Koblar, S. A., Gliniak, B. C., McKenna, H. J., Papayannopoulou, T., Thoma, B., et al. (1995) · Development · doi:10.1242/dev.121.5.1283 · Cited by 586
Tavernier, J., Devos, R., Cornelis, S., Tuypens, T., Van der Heyden, J., Fiers, W., & Plaetinck, G. (1991) · Cell · doi:10.1016/0092-8674(91)90040-6 · Cited by 575
IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
Kasaian, M. T., Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A., Witek, J. S., Senices, M., Konz, R. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00295-9 · Cited by 481
Zurawski, S. M., Vega, F., Huyghe, B., & Zurawski, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05927.x · Cited by 449
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin
Pandey, A., Ozaki, K., Baumann, H., Levin, S. D., Puel, A., Farr, A. G., Ziegler, S. F., Leonard, W. J., & Lodish, H. F. (2000) · Nature Immunology · doi:10.1038/76923 · Cited by 445
Self-citationReceptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5
Miyajima, A., Mui, A., Ogorochi, T., & Sakamaki, K. (1993) · Blood · doi:10.1182/blood.v82.7.1960.1960 · Cited by 416
Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor
Park, L. S., Martin, U., Garka, K., Gliniak, B., Di Santo, J. P., Muller, W., Largaespada, D. A., Copeland, N. G., Jenkins, N. A., Farr, A. G., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.659 · Cited by 415
Dumoutier, L., Leemans, C., Lejeune, D., Kotenko, S. V., & Renauld, J.-C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3545 · Cited by 405
Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells
Reche, P. A., Soumelis, V., Gorman, D. M., Clifford, T., Liu, M.-R., Travis, M., Zurawski, S. M., Johnston, J., Liu, Y.-J., Spits, H., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.336 · Cited by 403
Hilton, D. J., Zhang, J. G., Metcalf, D., Alexander, W. S., Nicola, N. A., & Willson, T. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.497 · Cited by 401
Cloning of an Interleukin-3 Receptor Gene: a Member of a Distinct Receptor Gene Family
Itoh, N., Yonehara, S., Schreurs, J., Gorman, D. M., Maruyama, K., Ishii, A., Yahara, I., Arai, K.-I., & Miyajima, A. (1990) · Science · doi:10.1126/science.2404337 · Cited by 401
Cytokines and immunodeficiency diseases
Leonard, W. J. (2001) · Nature Reviews Immunology · doi:10.1038/35105066 · Cited by 390
Self-citationA distinct role for interleukin-13 in Th2-cell-mediated immune responses
McKenzie, G. J., Bancroft, A., Grencis, R. K., & McKenzie, A. N. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70134-4 · Cited by 385
Impaired Development of Th2 Cells in IL-13-Deficient Mice
McKenzie, G. J., Emson, C. L., Bell, S. E., Anderson, S., Fallon, P., Zurawski, G., Murray, R., Grencis, R., & McKenzie, A. N. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80625-1 · Cited by 381
Friend, S. L., Hosier, S., Nelson, A., Foxworthe, D., Williams, D. E., & Farr, A. G. (1994) · PubMed · Cited by 352
Noben-Trauth, N., Shultz, L. D., Brombacher, F., Urban, J. F., Gu, H., & Paul, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10838 · Cited by 344
Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain
Ozaki, K., Kikly, K., Michalovich, D., Young, P. R., & Leonard, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200360997 · Cited by 332
Self-citationThe interleukin-10 family of cytokines
Fickenscher, H., Hör, S., Küpers, H., Knappe, A., Wittmann, S., & Sticht, H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02149-4 · Cited by 331
Townsend, M. J., Fallon, P. G., Matthews, D. J., Smith, P., Jolin, H. E., & McKenzie, A. N. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00056-x · Cited by 328
Donaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H. F., Henderson, S. L., O'Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · PubMed · Cited by 321
Essential function of LIF receptor in motor neurons
Li, M., Sendtner, M., & Smith, A. (1995) · Nature · doi:10.1038/378724a0 · Cited by 319
Nishinakamura, R., Nakayama, N., Hirabayashi, Y., Inoue, T., Aud, D., Mcneil, T., Azuma, S., Yoshida, S., Toyoda, Y., Aral, K.-I., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90046-2 · Cited by 309
Robb, L., Drinkwater, C. C., Metcalf, D., Li, R., Köntgen, F., Nicola, N. A., & Begley, C. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9565 · Cited by 296
cDNA Cloning and Characterization of the Human Interleukin 13 Receptor α Chain
Aman, M. J., Tayebi, N., Obiri, N. I., Puri, R. K., Modi, W. S., & Leonard, W. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29265 · Cited by 281
Self-citationDonaldson, D. D., Whitters, M. J., Fitz, L. J., Neben, T. Y., Finnerty, H., Henderson, S. L., O’Hara, R. M., Beier, D. R., Turner, K. J., Wood, C. R., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2317 · Cited by 277
Caput, D., Laurent, P., Kaghad, M., Lelias, J.-M., Lefort, S., Vita, N., & Ferrara, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.28.16921 · Cited by 274
Wang, M., Tan, Z., Zhang, R., Kotenko, S. V., & Liang, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106043200 · Cited by 269
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
Elson, G. C. A., Lelièvre, E., Guillet, C., Chevalier, S., Plun-Favreau, H., Froger, J., Suard, I., de Coignac, A. B., Delneste, Y., Bonnefoy, J.-Y., et al. (2000) · Nature Neuroscience · doi:10.1038/78765 · Cited by 252
Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family
Senaldi, G., Varnum, B. C., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo, J., Elliott, G., McNinch, J., Shaklee, C. L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11458 · Cited by 251
Molecular Cloning and Biological Characterization of a Novel Murine Lymphoid Growth Factor
Sims, J. E., Williams, D. E., Morrissey, P. J., Garka, K., Foxworthe, D., Price, V., Friend, S. L., Farr, A., Bedell, M. A., Jenkins, N. A., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.671 · Cited by 236
Pleiotropy and redundancy: T cell-derived lymphokines in the immune response
Paul, W. E. (1989) · Cell · doi:10.1016/0092-8674(89)90121-9 · Cited by 231
Aversa, G., Punnonen, J., Cocks, B. G., de Waal Malefyt, R., Vega, F., Zurawski, S. M., Zurawski, G., & de Vries, J. E. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2213 · Cited by 221
NEW EMBO MEMBERS' REVIEW: Receptor recognition by gp130 cytokines
Bravo, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.11.2399 · Cited by 211
Nishinakamura, R., Miyajima, A., Mee, P., Tybulewicz, V., & Murray, R. (1996) · Blood · doi:10.1182/blood.v88.7.2458.bloodjournal8872458 · Cited by 208
Quentmeier, H., Drexler, H., Fleckenstein, D., Zaborski, M., Armstrong, A., Sims, J., & Lyman, S. (2001) · Leukemia · doi:10.1038/sj.leu.2402175 · Cited by 192
IL-4 and IL-13 receptors: are they one and the same?
Callard, R. E., Matthews, D. J., & Hibbert, L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80600-1 · Cited by 181
Role of Oncostatin M in hematopoiesis and liver development
Miyajima, A., Kinoshita, T., Tanaka, M., Kamiya, A., Mukouyama, Y., & Hara, T. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00003-4 · Cited by 153
Severe Combined Immunodeficiency Due to a Specific Defect in the Production of Interleukin-2
Weinberg, K. I., & Parkman, R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222406 · Cited by 148
Smerz-Bertling, C., & Duschl, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.966 · Cited by 133
Cavazzana, M., Hacein‐Bey‐Abina, S., Basile, G. D. S., de Coene, C., Selz, F., Deist, F. L., & Fischer, A. (1996) · Blood · doi:10.1182/blood.v88.10.3901.bloodjournal88103901 · Cited by 112
Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.
Pahwa, S. G., Chatila, T. A., Pahwa, S. G., et al. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.5069 · Cited by 101
Molecular cloning of a novel type 1 cytokine receptor similar to the common gamma chain
Fujio, K., Nosaka, T., Kojima, T., Kawashima, T., Yahata, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Yamamoto, K., Nishimura, T., et al. (2000) · Blood · doi:10.1182/blood.v95.7.2204 · Cited by 61
Molecular cloning of a human novel type I cytokine receptor related to δ1/TSLPR
Tonozuka, Y., Fujio, K., Sugiyama, T., Nosaka, T., Hirai, M., & Kitamura, T. (2001) · Cytogenetic and Genome Research · doi:10.1159/000056941 · Cited by 60
Leonard, W. J. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90152-x · Cited by 55
Self-citationInterleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors
Renard, N., Duvert, V., Banchereau, J., et al. (1994) · Blood · doi:10.1182/blood.v84.7.2253.2253 · Cited by 50
Hiroyama, T., Iwama, A., Morita, Y., Nakamura, Y., Shibuya, A., & Nakauchi, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2764 · Cited by 34
Cited by
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,352
De novo design of potent and selective mimics of IL-2 and IL-15
Silva, D.-A., Yu, S., Ulge, U. Y., Spangler, J. B., Jude, K. M., Labão-Almeida, C., Ali, L. R., Quijano-Rubio, A., Ruterbusch, M., Leung, I., et al. (2019) · Nature · doi:10.1038/s41586-018-0830-7 · Cited by 531
A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis
Janes, K. A., Albeck, J. G., Gaudet, S., Sorger, P. K., Lauffenburger, D. A., & Yaffe, M. B. (2005) · Science · doi:10.1126/science.1116598 · Cited by 531
Molecular and Structural Basis of Cytokine Receptor Pleiotropy in the Interleukin-4/13 System
LaPorte, S. L., Juo, Z. S., Vaclavikova, J., Colf, L. A., Qi, X., Heller, N. M., Keegan, A. D., & Garcia, K. C. (2008) · Cell · doi:10.1016/j.cell.2007.12.030 · Cited by 517
Metadata
- Authors
- Ozaki, K., & Leonard, W. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-08
- Volume
- 277
- Issue
- 33
- Pages
- 29355-29358
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1996606664
- Cited by
- 350
- References
- 72
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.